Insomnia Market By Therapy Type (Pharmacological Therapy and Non Pharmacological Therapy), By Drug Formulation (Capsules and Tablets), By Type of Diseases (Poor Quality of Sleep and Sleep Maintenance), and By Region - Trends, Analysis and Forecast till 2030

Report Code: PMI23919 | Publish Date: March 2024 | No. of Pages: 178

Global Insomnia Market By Market Companies

  • Eisai, Co.
  • Pfizer, Inc.
  • Merck & Co Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Company
  • Meda Consumer Healthcare Inc.
  • Pernix Therapeutics
  • Purdue Pharma L.P.
  • Consumer Healthcare Inc.
  • Dainippon Sumitomo Pharma Ltd.

Recent News:

  • In June 2020, Eisai Co., Ltd. announced that its U.S. subsidiary Eisai Inc. has launched its in-house discovered orexin receptor antagonist DAYVIGO™ (lemborexant) CIV for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance in the U.S.